Great references as always Tony. On same site i noticed this re MS. Shame we cant get amongst that also although i guess anything can happen once first application takes off. This one Currently delivered via AAV to liver cells. I think we suggested we could already penetrate liver cells successfully. If nothing else i guess it goes to show the developing landscape for this technology.
https://www.mdmag.com/medical-news/new-gene-therapy-could-reverse-even-cure-ms
Ann: March 2019 Quarterly Operational Update and App4C, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
0.005(0.40%) |
Mkt cap ! $740.7M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.29 | $1.27 | $406.0K | 319.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13987 | $1.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 1380 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |